<SEC-DOCUMENT>0001193125-16-795948-index.html : 20161216
<SEC-HEADER>0001193125-16-795948.hdr.sgml : 20161216
<ACCEPTANCE-DATETIME>20161216172431
ACCESSION NUMBER:		0001193125-16-795948
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20161215
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161216
DATE AS OF CHANGE:		20161216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37923
		FILM NUMBER:		162057181

	BUSINESS ADDRESS:	
		STREET 1:		AESCHENVORSTADT 36
		CITY:			BASEL
		STATE:			V8
		ZIP:			4051
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		AESCHENVORSTADT 36
		CITY:			BASEL
		STATE:			V8
		ZIP:			4051
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d283294d8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: d283294d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d283294dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 2 - file: d283294dex101.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d283294dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 3 - file: d283294dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g283294logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g283294logo1.jpg

</DOCUMENT>
</SEC-DOCUMENT>